Decreased CTLA4+ and Foxp3+ CD25highCD4+ cells in induced sputum from patients with mild atopic asthma

Allergology International

Volumn 62, Issue 2, 2013, Pages 203-213

  Kawayama, Tomotaka ^a   Matsunaga, Kazuko ^a   Kaku, Yoichiro ^a   Yamaguchi, Kyoko ^a   Kinoshita, Takashi ^a,b   O'Byrne, Paul M ^b   Hoshino, Tomoaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Adult asthma; Airway hyperresponsiveness; Airway inflammation; Atopic asthma; Regulatory T cells

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; SALBUTAMOL; TRANSCRIPTION FACTOR FOXP3;

ADULT; ALLERGIC ASTHMA; ARTICLE; BLOOD ANALYSIS; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; SPUTUM ANALYSIS;

EID: 84878984631     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.12-OA-0492     Document Type: Article

References (37)

1. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010;10:490-500.
2. Dehzad N, Bopp T, Reuter S et al. Regulatory T cells more effectively suppress Th1-induced airway inflammation compared with Th2. J Immunol 2011;186:2238-44.
3. Venuprasad K, Kong YC, Farrar MA. Control of Th2-mediated inflammation by regulatory T cells. Am J Pathol 2010;177:525-31.
4. Miyara M, Wing K, Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009;123:749-55; quiz 756-7.
5. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-13.
6. Green JM. The B7 CD28 CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am J Respir Cell Mol Biol 2000;22:261-4.
7. Pandiyan P, Gartner D, Soezeri O, Radbruch A, Schulze-Osthoff K, Brunner-Weinzierl MC. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med 2004;199:831-42.
8. Hoff H, Knieke K, Cabail Z et al. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells. J Immunol 2009;182:5342-51.
9. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009;229:12-26.
10. Carreno BM, Bennett F, Chau TA et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000;165:1352-6.
11. Kawayama T, Gauvreau GM, Yokoyama T et al. Different profiles of CTLA-4 positive CD25+CD4+ T cells in allergen-induced early and dual responders with asthma [abstract]. Am J Respir Crit Care Med 2005;A289.
12. Kawayama T, Kinoshita T, Imaoka H, Gauvreau GM, O'Byrne PM, Aizawa H. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics. Respirology 2008;13: 1000-7.
13. Provoost S, Maes T, van Durme YM et al. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009;64:1539-46.
14. Hartl D, Koller B, Mehlhorn AT et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007;119:1258-66.
15. Smyth LJ, Eustace A, Kolsum U, Blaikely J, Singh D. Increased airway T regulatory cells in asthmatic subjects. Chest 2010;138:905-12.
16. Thunberg S, Gafvelin G, Nord M et al. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 2010;65:311-8.
17. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167:1245-53.
18. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003;33:215-23.
19. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated December 2010. Available at: http:www.ginasthma.org.
20. Miller MR, Crapo R, Hankinson J et al. General considerations for lung function testing. Eur Respir J 2005;26:153-61.
21. The Committee of Pulmonary Physiology JRS. [Guidelines for Pulmonary Function Tests. Spirometry, Flow Volume Curve, Diffusion Capacity of the Lung]. Tokyo: The Japanese Respiratory Society, 2004 (in Japanese).
22. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
23. Pin I, Gibson PG, Kolendowicz R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
24. Pizzichini E, Pizzichini MM, Efthimiadis A et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
25. Yoshida M, Watson RM, Rerecich T, O'Byrne PM. Different profiles of T-cell IFN-gamma and IL-12 in allergeninduced early and dual responders with asthma. J Allergy Clin Immunol 2005;115:1004-9.
26. Strauss L, Bergmann C, Whiteside TL. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol 2009;182:1469-80.
27. Kono K, Kawaida H, Takahashi A et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006;55:1064-71.
28. Kim BS, Kim IK, Park YJ et al. Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2mediated allergic asthma. Proc Natl Acad Sci U S A 2010; 107:8742-7.
29. Lee SY, Lee YH, Shin C et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002;122:171-6.
30. Friedline RH, Brown DS, Nguyen H et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009;206:421-34.
31. Wing K, Onishi Y, Prieto-Martin P et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322: 271-5.
32. Tang AL, Teijaro JR, Njau MN et al. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J Immunol 2008;181:1806-13.
33. Karagiannidis C, Akdis M, Holopainen P et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-33.
34. Ahmed A, Mukherjee S, Nandi D. Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD 152)-CD80 CD86 interactions in CD4(+) T lymphocytes. Immunology 2009;126:363-77.
35. Mukherjee S, Maiti PK, Nandi D. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin. J Leukoc Biol 2002;72:921-31.
36. O'Hehir RE, Gardner LM, de Leon MP et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009;180:936-47.
37. Khan S, Burt DJ, Ralph C et al. Tremelimumab (antiCTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells. Clin Immunol 2011;138:85-96.